Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Five Prime Therapeutics and Zai Lab start Phase 3 study of bemarituzumab for advanced gastric cancer California-based Five Prime Therapeutics and Chinese biopharma Zai Lab have initiated a pivotal Phase 3 trial of bemarituzumab… bypharmanewsdailyOctober 1, 2018